Personalized neurodiagnostics
with
explainable AI

The mission

"Baba’s mission is to enable personalized clinical decision-making in dementia and other neurological conditions, by facilitating precise and individualized treatment administration with explainable AI."

"Leonardsen, E. H. et al (2024). Constructing personalized characterizations of structural brain aberrations in patients with dementia using explainable artificial intelligence. npj Digital Medicine, 7(1), 110."

A clinical decision support tool that offers

RISK
PROFILING

Preemptively predict what patients are at risk of developing complications if they are given a treatment, based on data available at baseline.

SUBGROUP
STRATIFICATION

Determine whether a patient cohort can be divided into smaller groups for more accurate follow-up and treatment

PERSONALIZED
MONITORING

Continuously monitor and predict the risk of forthcoming complications based on longitudinal data, to identify patients that should stop treatment due to their predicted risk trajectories.

Why? Healthcare are not prepared to handle the surge of dementia patients

There are more than 55 million people living with dementia globally. Estimated 10 million new cases per year.

New Alzheimers treatments are becoming available, however, they are not eligible for 80-90% of patients due to the risk of severe side effects.

Tools that guide clinical decisions can help more patients get access to treatment, and are necessary to administer safe and effective treatments.

Collaborations